HYBRID EVENT: Join us in person in Tokyo, Japan or attend virtually from anywhere.
Cancer metabolism refers to the distinct ways in which cancer cells alter their energy production and nutrient utilization compared to normal cells. Unlike healthy cells that primarily rely on aerobic respiration for energy, cancer cells often exhibit a preference for glycolysis, even in the presence of oxygen, a phenomenon known as the Warburg effect. The Warburg effect involves the increased conversion of glucose to lactate, promoting rapid energy generation and providing essential building blocks for the synthesis of macromolecules crucial for cancer cell proliferation. This metabolic shift is considered a hallmark of cancer, contributing to the aggressiveness and survival of malignant cells. Additionally, cancer cells display heightened nutrient uptake and reprogrammed metabolic pathways to sustain their uncontrolled growth. They manipulate various signaling pathways to enhance nutrient acquisition, such as increased glutamine metabolism and altered lipid synthesis. These metabolic adaptations not only support the energetic demands of rapid cell division but also confer resistance to apoptosis, allowing cancer cells to evade the body's natural defense mechanisms. Understanding the intricacies of cancer metabolism is crucial for developing targeted therapeutic strategies. Researchers aim to exploit these metabolic vulnerabilities to develop drugs that selectively disrupt cancer cell metabolism while sparing normal cells. By unraveling the complex metabolic rewiring in cancer, scientists strive to uncover novel therapeutic avenues that hold promise in the ongoing battle against this devastating disease.
